Mucoepidermoid Carcinoma - Long Answer (BDS Examination Format)

Definition

Incidence and Epidemiology

• Represents approximately 15% of all salivary gland tumors, making it the single most common salivary gland malignancy
• It accounts for approximately 34% of all malignant salivary gland tumors (Spiro's landmark review of 1278 cases)
• Site distribution:
  • Parotid gland: 60-70% of cases (most common major salivary gland site)
  • Minor salivary glands: particularly the hard palate, buccal mucosa, lip, and retromolar trigone
  • Submandibular and sublingual glands: less frequent
  • Central (intraosseous) MEC: arises within the mandible or maxilla from odontogenic epithelium; less aggressive behavior
• Age: Peak incidence around 45 years of age; can occur in children - in fact, MEC is the most common pediatric salivary gland carcinoma
• Sex: Slightly more common in women

Etiology and Pathogenesis

• A consistent chromosomal translocation t(11;19)(q21;p13) is found in more than 50% of MECs
• This creates a CRTC1::MAML2 fusion gene (also written as MECT1-MAML2)
• The MAML2 portion of the fusion protein cannot interact with Notch signaling components, perturbing both Notch and cAMP-dependent signaling pathways
• This translocation is associated with better prognosis and is diagnostically useful (especially in low- and intermediate-grade tumors)
• High-grade MECs are often negative for this translocation

Clinical Features

• Patients typically present with a painless, slow-growing mass
• In the parotid region, it appears as a firm or fluctuant swelling
• In the oral cavity (especially hard palate and buccal mucosa), it may appear as a bluish, fluctuant swelling that mimics a mucocele - this is due to mucin within cystic spaces imparting a blue color
• Pain, ulceration, and facial nerve involvement can occur, especially in high-grade tumors
• Intraosseous MEC may appear as a radiolucency on radiograph

Gross Pathology

• Tumors may grow up to 8 cm in diameter
• Appears circumscribed but lacks a well-defined capsule and is often infiltrative
• Cut surface is pale gray to white
• Frequently contains small, mucin-filled cysts
• Usually has both solid and cystic components

Histopathology

Three Cell Types (Classic Triad)

• Architecture: mixture of cystic and solid elements - sheets, nests, duct-like structures, and cysts
• Mucin can be highlighted with special stains: PAS, Mucicarmine, or Alcian blue
• True keratinization is rare in MEC; its presence should raise suspicion for adenosquamous carcinoma
• Immunohistochemistry is of limited utility in diagnosis

Histological Appearances:

Histological Grading

Auclair Grading System

Brandwein Grading System (Modification - more stringent)

Low-Grade vs. High-Grade MEC - Comparative Features

Differential Diagnosis

1. Mucocele - benign, no epithelial lining with true malignant cells; clinically mimics low-grade MEC in oral cavity
2. Necrotizing sialometaplasia - non-neoplastic reactive lesion of hard palate minor salivary glands; important differential in oral cavity MECs
3. Adenosquamous carcinoma - aggressive variant of SCC; has definitive squamous differentiation with keratinization (unlike MEC), surface mucosal squamous dysplasia, and more aggressive behavior
4. Pleomorphic adenoma - benign; myxochondroid areas absent in MEC; no infiltrative growth
5. Adenoid cystic carcinoma - basoloid cells with dark chromatin, cribriform ("Swiss cheese") pattern; perineural invasion prominent

Special Investigations

1. Fine Needle Aspiration Cytology (FNAC): Yields mixture of mucinous, intermediate, and squamoid cells; both glandular and squamoid components must be present for diagnosis
2. Special stains: PAS, Mucicarmine, Alcian blue - to confirm mucin in cells
3. Molecular/Cytogenetics: CRTC1::MAML2 fusion gene (from t(11;19) translocation) - useful for confirmation, especially in low/intermediate-grade tumors
4. Imaging (CT/MRI): For extent of disease, bone involvement, and lymph node assessment

Treatment

• Surgery is the primary treatment - wide local excision with adequate margins
  • For parotid MEC: superficial or total parotidectomy depending on extent
  • For submandibular gland: complete excision
  • For minor salivary gland MEC: wide local excision
• Neck dissection: Indicated for clinical adenopathy or high-grade tumors
• Postoperative radiotherapy: Recommended for high-grade tumors, close/positive margins, perineural invasion, or lymph node metastasis
• Low-grade MECs of the submandibular gland recur and metastasize more frequently than parotid/minor salivary gland MECs of the same grade - warranting aggressive resection

Prognosis

• The CRTC1::MAML2 fusion is associated with better prognosis but this is not independent of tumor grade
• Clinical staging is equally important as histologic grade and must be considered together

Summary Points for Exam

1. MEC = most common primary malignant salivary gland tumor
2. Three cell types: mucous, squamoid (epidermoid), and intermediate cells
3. Most common site: parotid gland (60-70%)
4. Most common intraoral minor salivary gland site: hard palate
5. Most common salivary gland malignancy in children
6. Molecular marker: CRTC1::MAML2 fusion (t(11;19)(q21;p13))
7. Grading: three grades - low, intermediate, high (Auclair or Brandwein system)
8. Special stains for mucin: PAS, Mucicarmine, Alcian blue
9. True keratinization is rare - if present, consider adenosquamous carcinoma
10. Treatment: surgery ± postoperative radiotherapy based on grade/stage